134 related articles for article (PubMed ID: 11301319)
1. The effect of substrate, dihydrobiopterin, and dopamine on the EPR spectroscopic properties and the midpoint potential of the catalytic iron in recombinant human phenylalanine hydroxylase.
Hagedoorn PL; Schmidt PP; Andersson KK; Hagen WR; Flatmark T; Martínez A
J Biol Chem; 2001 Jun; 276(25):22850-6. PubMed ID: 11301319
[TBL] [Abstract][Full Text] [Related]
2. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
[TBL] [Abstract][Full Text] [Related]
3. Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme.
Knappskog PM; Flatmark T; Aarden JM; Haavik J; Martínez A
Eur J Biochem; 1996 Dec; 242(3):813-21. PubMed ID: 9022714
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine, and its implications for the mechanism of catalysis and substrate activation.
Andersen OA; Flatmark T; Hough E
J Mol Biol; 2002 Jul; 320(5):1095-108. PubMed ID: 12126628
[TBL] [Abstract][Full Text] [Related]
5. A comparison of kinetic and regulatory properties of the tetrameric and dimeric forms of wild-type and Thr427-->Pro mutant human phenylalanine hydroxylase: contribution of the flexible hinge region Asp425-Gln429 to the tetramerization and cooperative substrate binding.
Bjørgo E; de Carvalho RM; Flatmark T
Eur J Biochem; 2001 Feb; 268(4):997-1005. PubMed ID: 11179966
[TBL] [Abstract][Full Text] [Related]
6. High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin.
Andersen OA; Flatmark T; Hough E
J Mol Biol; 2001 Nov; 314(2):279-91. PubMed ID: 11718561
[TBL] [Abstract][Full Text] [Related]
7. Use of surface plasmon resonance for real-time measurements of the global conformational transition in human phenylalanine hydroxylase in response to substrate binding and catalytic activation.
Flatmark T; Stokka AJ; Berge SV
Anal Biochem; 2001 Jul; 294(2):95-101. PubMed ID: 11444803
[TBL] [Abstract][Full Text] [Related]
8. The active site residue tyrosine 325 influences iron binding and coupling efficiency in human phenylalanine hydroxylase.
Miranda FF; Kolberg M; Andersson KK; Geraldes CF; Martínez A
J Inorg Biochem; 2005 Jun; 99(6):1320-8. PubMed ID: 15917086
[TBL] [Abstract][Full Text] [Related]
9. Probing cofactor specificity in phenylalanine hydroxylase by molecular dynamics simulations.
Teigen K; Martinez A
J Biomol Struct Dyn; 2003 Jun; 20(6):733-40. PubMed ID: 12744702
[TBL] [Abstract][Full Text] [Related]
10. The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: implications for the catalytic mechanism.
Teigen K; Frøystein NA; Martínez A
J Mol Biol; 1999 Dec; 294(3):807-23. PubMed ID: 10610798
[TBL] [Abstract][Full Text] [Related]
11. Studies on the regulatory properties of the pterin cofactor and dopamine bound at the active site of human phenylalanine hydroxylase.
Solstad T; Stokka AJ; Andersen OA; Flatmark T
Eur J Biochem; 2003 Mar; 270(5):981-90. PubMed ID: 12603331
[TBL] [Abstract][Full Text] [Related]
12. L-phenylalanine binding and domain organization in human phenylalanine hydroxylase: a differential scanning calorimetry study.
Thórólfsson M; Ibarra-Molero B; Fojan P; Petersen SB; Sanchez-Ruiz JM; Martínez A
Biochemistry; 2002 Jun; 41(24):7573-85. PubMed ID: 12056888
[TBL] [Abstract][Full Text] [Related]
13. EPR and 1H-NMR spectroscopic studies on the paramagnetic iron at the active site of phenylalanine hydroxylase and its interaction with substrates and inhibitors.
Martínez A; Andersson KK; Haavik J; Flatmark T
Eur J Biochem; 1991 Jun; 198(3):675-82. PubMed ID: 1646718
[TBL] [Abstract][Full Text] [Related]
14. Structural comparison of bacterial and human iron-dependent phenylalanine hydroxylases: similar fold, different stability and reaction rates.
Erlandsen H; Kim JY; Patch MG; Han A; Volner A; Abu-Omar MM; Stevens RC
J Mol Biol; 2002 Jul; 320(3):645-61. PubMed ID: 12096915
[TBL] [Abstract][Full Text] [Related]
15. The accessibility of iron at the active site of recombinant human phenylalanine hydroxylase to water as studied by 1H NMR paramagnetic relaxation. Effect of L-Phe and comparison with the rat enzyme.
Olafsdottir S; Martínez A
J Biol Chem; 1999 Mar; 274(10):6280-4. PubMed ID: 10037716
[TBL] [Abstract][Full Text] [Related]
16. Conformation of the substrate and pterin cofactor bound to human tryptophan hydroxylase. Important role of Phe313 in substrate specificity.
McKinney J; Teigen K; Frøystein NA; Salaün C; Knappskog PM; Haavik J; Martínez A
Biochemistry; 2001 Dec; 40(51):15591-601. PubMed ID: 11747434
[TBL] [Abstract][Full Text] [Related]
17. Redox function of tetrahydrobiopterin and effect of L-arginine on oxygen binding in endothelial nitric oxide synthase.
Berka V; Yeh HC; Gao D; Kiran F; Tsai AL
Biochemistry; 2004 Oct; 43(41):13137-48. PubMed ID: 15476407
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure and site-specific mutagenesis of pterin-bound human phenylalanine hydroxylase.
Erlandsen H; Bjørgo E; Flatmark T; Stevens RC
Biochemistry; 2000 Mar; 39(9):2208-17. PubMed ID: 10694386
[TBL] [Abstract][Full Text] [Related]
19. Modeled ligand-protein complexes elucidate the origin of substrate specificity and provide insight into catalytic mechanisms of phenylalanine hydroxylase and tyrosine hydroxylase.
Maass A; Scholz J; Moser A
Eur J Biochem; 2003 Mar; 270(6):1065-75. PubMed ID: 12631267
[TBL] [Abstract][Full Text] [Related]
20. Substrate-induced conformational transition in human phenylalanine hydroxylase as studied by surface plasmon resonance analyses: the effect of terminal deletions, substrate analogues and phosphorylation.
Stokka AJ; Flatmark T
Biochem J; 2003 Feb; 369(Pt 3):509-18. PubMed ID: 12379147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
